/Lists

Biotech Investors & VC Firms in New York

171 firms in this list, with a median first check of $500K. 43 of them lead rounds. Generated from verified public data and updated continuously.

General Atlantic
New YorkSeries B–Late Stage$10M – $1B
534 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
81 people
New Mountain Capital
New YorkGrowth
233 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
227 people
OrbiMed
New YorkSeed–Late Stage$1M – $75M
93 people
Deerfield Management Company
New YorkSeed–Late Stage
144 people
Cerberus Capital Management
New YorkPre-Seed–Seed
163 people
Lux Capital
New YorkPre-Seed–Series B$100K – $100M
46 people
Lerer Hippeau
New YorkSeed–Series B$500K – $2M
22 people
Arsenal
New YorkGrowth
111 people
SK Capital Partners
New YorkGrowth–Late Stage
95 people
Cerity Partners Ventures
New YorkSeed–Late Stage
61 people
WCAS
New YorkGrowth
91 people
AlleyCorp
New YorkPre-Seed–Series A$1M – $5M
29 people
HOF Capital
New YorkPre-Seed–Growth$500K – $10M
45 people
Owl Rock Capital
New YorkGrowth–Late Stage
14 people
2048 Ventures
New YorkPre-Seed–Seed$500K – $3M
49 people
Winklevoss Capital
New YorkPre-Seed–Series A$100K – $5M
5 people
NYU Innovation Venture Fund
New YorkPre-Seed–Series A$100K – $500K
34 people
Everywhere Ventures
New YorkPre-Seed–Seed$250K
30 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
37 people
Casdin Capital
New YorkSeed–Series C
39 people
Oxeon Partners
New YorkSeed–Series A
60 people
Two Sigma Ventures
New YorkSeed–Series B$2M – $15M
26 people

Frequently asked questions

Who are the top biotech investors & vc firms in new york?
Top biotech investors & vc firms in new york include General Atlantic, SOSV, New Mountain Capital, Blackstone Life Sciences, OrbiMed, Deerfield Management Company, Cerberus Capital Management, Lux Capital — 171 firms in total meet the criteria.
What is the typical first check among biotech investors & vc firms in new york?
The median first check among the 171 biotech investors & vc firms in new york tracked here is $500K.
How many biotech investors & vc firms in new york lead rounds?
43 of the 171 biotech investors & vc firms in new york tracked here lead investment rounds.

Related lists

Data sourced from public filings and firms' own websites — see our methodology.